GeneDx Holdings (WGS) Net Margin (2020 - 2026)

GeneDx Holdings has disclosed Net Margin across 7 years of filings, most recently posting 61.92% for Q1 2026.

• In Q1 2026, Net Margin fell 5448.0% year-over-year to 61.92%; the TTM figure through Mar 2026 stood at 17.58% (down 591.0% YoY), while the FY2025 annual figure was 4.92%, up 1220.0% from the prior year.
• Net Margin slipped to 61.92% in Q1 2026, from 14.64% in the prior quarter.
• Over the last five years, Net Margin for WGS reached as high as 10.53% in Q2 2025 and fell as low as 503.21% in Q4 2022.
• The 5-year median for Net Margin is 44.86% (2023), against an average of 88.02%.
• Annual changes were most pronounced in 2022 — Net Margin slumped 43369 bps — and 2023, when it surged 45835 bps.
• A 5-year view of Net Margin shows it stood at 503.21% in 2022, then soared by 91 bps to 44.86% in 2023, then surged by 113 bps to 5.69% in 2024, then tumbled by 357 bps to 14.64% in 2025, then plunged by 323 bps to 61.92% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 61.92%, 14.64%, and 6.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.